It is important to determine the influence of surface modifications of particle characteristics on internalization of different macrophages phenotypes. Here we demonstrated that modified surfaces impact particle internalization and this internalization is dependent on macrophage phenotype. Our data revealed that surface modifications alter the zeta potential and negligibly change particle size. Internalization is tunable through alterations in zeta potential and hydrophobicity. These findings demonstrated that targeted drug delivery to macrophages could be achieved by exploiting material parameter.
INTRODUCTION

Targeted Drug Delivery
Drug delivery is a method or process of administering a pharmaceutical active compound to achieve a therapeutic effect in humans or animals 1 . In modern society, nanoparticle drug delivery systems play important roles in cancer treatment. 2 Cancer is already the second major cause of death in the US and the Agency for Healthcare research and Quality (AHRQ) estimates that the direct medical costs for cancer in the US in 2011
were $88.7 billion. 3 There are more than one billion case diagnosed annually and around 600,000 people will die from cancer this year, which is 1,600 deaths per day. 3 The goal of targeted drug delivery is to release the maximum amount of medication at the site of injury or disease and reduce the drug distribution in the whole body, thus reducing or eliminating offtarget effects. To achieve this goal, the requirements for the drug delivery vehicle are: 1) a high drug loading capacity, 2) long circulation time, 3) appropriate release rates, and 4) nonspecific interaction with the host immune system. 4 Nanoparticles coupled to ligands have the potential to achieve these requirements and be a "magic bullets" 5 to shoot the desired sites.
Passive delivery is commonly used in the clinic for targeting tumor sites. Due to the larger pore size of blood vessels supplying tumors, aggressive tumors inherently develop leaky vasculature. Increased retention resulting from poor lymphatic drainage in tumors of nanoparticles and permeation within the tumor region allow extravasation to enhance drug delivery effects at the tumor site. 6 This is called the enhanced permeability and retention (EPR) effect, which is the most common method of passive targeting. Tumor specificity is enhanced due to the differential accumulation of encapsulated nanoparticles, which is largely influenced by particle size. Owing to the tight junctions of capillaries, passive targeting allows for increased drug concentration at the tumor site. 7 There are various factors that influence passive targeting. Size, surface properties, molecule weight, and polymer or particle fabrication method all impact tumor uptake.
Hydrophobic particles around 200 nm have shown higher plasma resident time, which enhances the EPR effect. 8 Many other factors have been reported from clinical studies such as surface charge, hydrophobicity, and immunogenicity 9 of the drug carriers; therefore, due to the complexity of the system, it is challenging to accurately predict material properties that will enhance tumor uptake.
To overcome the limitations of passive targeting, the idea of active targeting has been proposed, which involves the attachment of a ligand or molecule onto the surface of the drug delivery vehicle that can specifically bind to an overexpressed cell membrane receptor specific to the target cell. 2 Identification of specific tumor biomarkers is crucial for efficient active targeting with limited off target effects resulting from expression of receptors on healthy cells. It has been reported that active targeting improves the therapeutic index to tumors in mice. 10 The density of expressed targeted receptors on the cell surface is another determining factor for the success of active targeting. Increased specificity contributes to enhance antibody-mediated drug delivery, which is hindered by high cost and long production time. 11 Macrophage internalization mechanisms are complex, and include macropinocytosis, endocytosis, and phagocytosis. 20 Macropinocytosis is the major uptake pathway for extracellular fluids, solutes, macro-or small particles. 21 Endocytosis is the general term to define the process for importing selected molecules, viruses, microorganisms, and nanometer sized particles. This process includes clathrin-dependent and independent receptor-mediated endocytosis. 22 Receptor-mediated endocytosis is the most effective mechanism for nanoparticle delivery to cells. 23 Ligands decorating the surface of the nanoparticle could bind to cell receptors, resulting in membrane invagination. 79 Phagocytosis is a mechanism by which foreign particles such as dead cells, pathogens and digesting drug particles can enter cells. During the process of phagocytosis, the phagocyte-bound pathogen is surrounded by a phagocyte membrane and encapsulated in the phagosome, which is a membrane bound vesicle. 24 With the fusion of the phagosome and lysosome, the phagolysosomes digest internalized material. 25 However, the process of lysis of pathogenic microorganism leads to the generation of other toxic composition such as NO, hydrogen peroxide, and superoxide anion, which damage the healthy host cells. 26 The response of a phagocyte to a target can be multilayered, which is shown in Fig 1. 1 25 The responses of effective clearance of pathogenic microorganisms are: 1) surface receptors detect the microorganism and engulf and kill them and 2) internalized targets are presented as antigens to T cells.
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Figure1.1 Information processing at different stages of phagocytosis 25 As phagocytosis proceeds from the initial binding of a target to actin-dependent internalization and ultimately to degradation of the target in the phagolysosome, myeloid cells acquire information about the target through a variety of mechanisms. At the cell surface, receptors sample the chemical constituents of the particle and membrane dynamics facilitate an assessment of its physical properties. Additional information is gathered as the phagosome pinches off from the plasma membrane and as it matures through interactions with other intracellular compartments. Finally, the degradation of the target exposes ligands that were not previously accessible and releases ligands into the cytosol for detection by intracellular receptors. The information gathered by all of these processes is integrated to shape the ensuing immune response.
Although more receptors need to be identified, some receptors have been definitively shown to be mediate phagocytosis. Fc receptors could be used to recognize antibodyopsonized particles and initiate numerous signal pathways through two subtype receptors: activation receptors and inhibitory receptors. 27 However, most targets engage several receptors on the phagocytes' surface, making it hard to define the exact role of the individual receptors in internalization.
Macrophage reprograming plays an important role in cancer treatment and can offer potential antitumor activities. For health bodies, macrophages are a kind of protector, producing inflammatory mediators (cytokines and reactive oxygen species) and activating adaptive immune cells. 28 In the early stages of tumor growth, large quantities of inflammatory mediators are produced and a cancer-related inflammatory microenvironment is generated, 29 inducing tumor cell proliferation or genetic instabilities in the healthy cells.
The early tumor development stage is characterized by an M1-like polarized inflammatory environment. 28 Production of IL-10, low levels of inflammatory cytokines, and reactive oxygen intermediates, along with poor antigen expressing abilities are characteristic of macrophages in mature tumors, which are considered to adopt a more M2-like phenotype.
These cells are termed as tumor associated macrophages (TAMs). Thus, cancer could be considered a disease that is promoted by the permissive environment created by macrophages. Reprogramming the macrophages, from TAMs to M1-like phenotype, is a promising method to develop anti-tumor therapies.
Liposomes
Since the 1960s liposomes have been described and used as drug delivery vehicles for chemotherapeutics in cancer therapy. 2 Currently, liposomes are one of the most widely investigated drug delivery systems and are used in the clinic. 30, 31 Seventeen liposomal drug formulations have been clinically approved and many more are in clinical trials. 32, 33 Solutes carried by liposomes been extended to chelating agents 34 , antibiotics 35 , hormones 36 , proteins 37 , and anti-tumor drugs. compare to unmodified liposomes. 12 Peptide HVGGSSV conjugated to liposomal doxorubicin has remarkable targeting ability and heightened cytotoxic effects. 44 Anti-HER2
PEGylated liposomes are preferentially internalized in HER2 + breast cancer HER2 compared to non-targeted liposomal formulation.
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Figure1.2 Schematic depicting a liposome generated using phospholipids, followed by a liposome surface modified to contain a targeting ligand specific for upregulated cell surface receptors present on a cancer cell. 2 Liposomes have been chosen as a therapeutic carrier owing to its advantages of: biocompatibility, preventing premature degradation of encapsulated cargo, entrapment of both hydrophilic and hydrophobic drugs, targeted delivery, site avoidance, and size and composition based tunable biodistribution. 46 Liposome structures are shown in Fig1.3.
However, the major limitation of liposomes is the fast elimination from the blood steam and recognition by the reticuloendothelial system. 47 Plasma proteins rapidly adsorb to liposomes and they can be eliminated through the mononuclear phagocytic system. Surface membranes coat with protein in a short time, which reduces the circulation time in blood. 48, 80 Figure1. 3 The schematic representation of the structure of liposome 46 Petros et al. 49 proposed that modifying the surface of liposomes with dysopsonins reduces recognition from complement components, such as the membrane attack complexes and inhibits phagocytosis from macrophages, neutrophils, and monocytes. Stealth liposomes have been coated with polymers to extend the circulation time such as PEG 41 , poly(vinyl pyrrolidone) (PVP) 50 , and amphiphilic polyacrylamide. 51 The blood circulation time has been increased and stability enhanced through these modifications. and arginase. The former produces citrulline and reactive nitrogen intermediates in M1 macrophages, and the latter produces ornithine and urea in M2 macrophages. 18 Some arginine derivatives have been investigated and have shown therapeutic effects. Nitroarginine has neuroprotective effects in Alzheimer' disease, Parkinson's disease, and AIDS. 63 Acetylcarnitine, involved in membrane stabilization and repair, reduces protein oxidation and toxic fatty acid ethyl esters in different organs. 64 In this study, we fabricated liposomes and modified their surfaces with 14 molecules chemically similar to arginine to investigate the effects of surface modifications on internalization by non-active macrophages. Also, we characterized the size and surface charge of both modified and unmodified liposomes. Finally, the liposomes were loaded with doxorubicin, an anti-cancer drug, and were examined for their loading efficiency and release kinetics at pH 7.4. Changes in the IC 50 of doxorubicin entrapped in the unmodified and modified liposomes was compared to that of free doxorubicin in M (LPS), M(IL-4), and M(0) macrophages.
Material And Methods
All materials were purchased through Sigma and were used as received, unless otherwise stated. Fresh deionized water (Milli-Q, Thermo Scientific Nanopure, Waltham, MA) was used throughout this study. Error bars indicated the standard deviation.
Liposome particle modification
In a 250 ml round-bottom flask, 1, 2-dioleoyl-sn-glycero-3-phosphoethanolamine This process repeated for all 14 surface modifiers. The particles were dialyzed overnight against Milli-Q water and lyophilized.
Figure2.1 Chemical structures of molecules used for the modification of liposomal particles.
The arginine derivatives shown here are lettered for easier identification in experiments and discussion throughout the chapter.
Zeta potential and dynamic light scattering
Milli-Q water was adjusted to pH 7 with HCl or NaOH to ensure the ions in the water would not influence the results by interference with the liposomes. To 5 ml H 2 O, 100 μl 1% w/v of particles were added and extruded through 100 nm polycarbonate membranes using an Avanti Mini-Extruder manual extruder (Avanti Polar Lipids, Inc.) 5 times for all 14 modified liposomes and unmodified liposomes. Zeta potential and particle size was measured with a Zetasizer Nano Z (Malvern).
Fluorescent particles and cellular uptake
To measure internalization of the liposomes by macrophages, 2mg of liposome particles were mixed with 1 ml FC (Fluorescein, 1 mg/mL in acetone). The liposomes were subsequently dried at 55 ℃ for 4 h and particles were resuspended in 2 ml PBS. The (1) where C sup is the concentration of doxorubicin in the supernatant and C total is the concentration of doxorubicin added to the liposomes.
Liposomes loaded with doxorubicin were placed in a dialysis membrane, and placed in a beaker with 100 mL of PBS. The beaker was sealed and incubated at 37 ℃. Aliquots of 1 ml were collected periodically and assayed spectrophotometrically with a plate reader at an absorbance of 490 nm with a reference at 630 nm. After sample was removed, 1 ml PBS was added to maintain a constant volume.
IC 50
RAW 264.7 cells (50,000 cells/well in 100 μL CM in every well except the negative control) were seeded into a 96 well plate for 24 h. A serial dilution of liposomes loaded with doxorubicin was added to the plate. A positive control was conducted without particles. After incubating for 48 h at 37°C, the media was aspirated and 10 μL of 5 mg/mL methyl thiazol tetrazolium (MTT) and 100 μL CM were added to each well. The plate was incubated at 37°C for 2 h. A volume of 85 μL was aspirated from each well and 100 μL DMSO were added to dissolve the insoluble formazan crystals. The optical density at 540 nm and a reference of 690 nm were measured with a plate reader. Data was normalized to cells cultured without particles and 6 replicates were obtained for each experiment.
Statistics and data analysis
Statistical analysis was performed using XLSTAT statistical software. Statistical significance of the mean comparisons was determined by ANOVA. Differences were considered statistically significant for p < 0.05.
Results
Liposome characterization
Subtle differences between the different modifiers were reflected in zeta potential values derived from the electrophoretic mobility measurements under identical experimental conditions. 2 Zeta potential represents the relative surface charge of particles, which contributes to particle internalization. 1 Fig2.2 A shows the zeta potential of both modified and unmodified liposomes. Unmodified liposome have a zeta potential of -16.8 ± 0.8 mV， which is similar of other reports. 65, 66 All modified liposomes were negatively charge over a wide range (from -8.9 to -33.9 mV), which may arise from the different functional groups of the modifiers.
Nanoparticle size is a determining factor in drug delivery. 1 Through dynamic light scattering, the diameter of the nanoparticles was measured (Fig2.2 B) . The unmodified liposome was found to be 96.3 ± 9.4 nm and the size of modified liposomes was measured to be ~100 nm, with the largest liposome being 108.8 ± 14.8 nm. The size of the unmodified liposome matches the previous reports. 67, 66 The polydispersity index (PDI) ranged from 0.096 to 0.167 for all of the particles.
Drug loading and release
A transmembrane pH gradient was employed as an active loading method to encapsulate doxorubicin in liposomes. 31 Through drug self-association and interaction with salts, doxorubicin precipitates in the aqueous core of liposome. 30 It is a direct method to encapsulate doxorubicin to achieve optimum efficiency and reduce costs. The loading efficiency (Fig2.3) shows that all liposomes have a loading efficiency of greater than 90%. Liposomes loaded with doxorubicin were incubated in PBS (pH 7.4) at 37 °C for 144 h to monitor drug release using the dialysis bag method. All of the liposomes released less than 15% of encapsulated doxorubicin after 144 h, as shown in Fig 2. 4, which indicates sustained release capability. Modification D has a lower release percentage compared to the unmodified liposome (p < 0.05). According to the B statistical analysis, there are no differences among the modified and unmodified liposomes (p > 0.05), indicating a uniform encapsulation capability.
Particle internalization
The unmodified and modified liposomes were loaded with FC and were incubated with RAW 264.7 macrophages to measure particle internalization. A constant particle concentration (0.1mg/ml) was used throughout the study. After incubation with the cells, the fluorescence of FC was quenched with trypan blue. Unmodified and all of the modified liposomes explored here are negatively charged, which has been reported to have higher association effects with cells and more efficient delivery than neutral liposomes when encapsulating methotrexate-γ-aspartate. 58 Previous studies have reported that the extent of phagocytosis increases with increasing zeta potential, both negative and positive, and was lowest when the zeta potential was zero. 58 Several similarities between alterations in the zeta potential value and internalization with FC and IC 50 values of encapsulated doxorubicin were observed. In internalization with FC, with the exceptions of modifications B, F, J, and N, the internalization of the particles follows the zeta potential with more negative liposome surface charges corresponding to higher FC uptake. In the IC 50 test, M(0) macrophages have increasing cytotoxicity with more negative zeta potential except in the case of medications C, G, H, I, and L. Attachment of liposomes to cell membranes is the first step of internalization, which is affected on surface changes of particles . 70 It has been suggested that there are cationic binding sites on cell surfaces that promote formation of clusters of negatively particles, owing to the repulsive interactions of the cell lipid membrane, thus improving internalization of negatively charged particles. 70 It is well known that charged particles become opsonized and enter cells through absorptive endocytosis. 71 Many positively charged liposomes exert toxic effects on cells, thus making negatively charged liposomes, such as those studied here, a more attractive carrier for drug delivery.
There were no significant differences in size between unmodified and modified liposomes after extrusion through 100 nm membranes, which provides uniform diameters and volumes. It has been reported that extrusion of liposomes could enhance the entrapment capability. 56 Small particle size (<200nm) is also known to enhance drug accumulation at the tumor site. 72 The high retention of doxorubicin in these liposomes demonstrates the strong and similar stability of particles due to the uniform liposome size (~100 nm), which has previously been demonstrated as a factor in high drug retention levels in liposomes. 67 The loading efficiency showed no significant differences across the library of modified liposomes.
Size has been reported in many studies 52, 45, 73 as a crucial factor in altering pharmacokinetics due to the impact on tissue distribution and clearance. 45 Several mechanisms for endosomal escape have been proposed. The proton sponge effects, also known as the pH-buffering effect, is mediated by agents with a high buffering capacity and the flexibility to swell when protonated. 75 An extensive inflow of ions and water induced by protonation into endosomal environment, results in cracking of the endosomal membrane and releasing the encapsulated contents. Poly (amido amine) s, which have protonated amine groups in their structure, contribute to a high buffer effect which results in increases in the osmotic pressure of the endosome and disrupts the endosomal membrane. 76 The flip-flop mechanism involves exchange of the liposomes in the endosomal wall and the delivered liposome, resulting in endosomal escape into cytosol. 77 Due to the electrostatic interaction between the cationic lipoplexes and the negatively charged lipids of the endosomal membrane, anionic lipids diffuse into the lipoplexes and form chargeneutralized ion pairs with cationic lipids. 78 Membrane fusion is the destabilization of the endosomal membrane due to fusogenic peptides, which is a significant process in cellular delivery and endocytosis. Haemeagglutin subnit HA2 of influenza virus change conformation when inside the endosomes due to the low pH environment and the highly conserved hydrophobic N-terminal region. This viral membrane fusion results in viral genome leakage to cytosol. 79 When liposomes interact with macrophages, the encapsulated drugs are taken by diffusing out of vehicles or directly "eaten" through lysosomal degradation. Escape from the liposome depends on the drug release rate from liposomes and macrophage permeability to the drugs. Doxorubicin loading efficiency has been shown in Fig 2. 3, demonstrating the low drug release rate.
Hydrophobicity is another factor that leads to a difference in internalization. It has been shown that hydrophobic liposomes are more susceptible to phagocytosis than their hydrophilic counterparts. 58 Here, the IC 50 values are remarkably influenced by hydrophobicity. For modifications C, I, and L, which show mismatches between internalization of FC encapsulated liposomes and zeta potentials, these differences can be explained by hydrophobicity. All three modifications demonstrate higher surface tensions, resulting in increased hydrophobicity. Most modifications have lower IC 50 values than unmodified liposomes when comparing similar macrophage activations, indicating improvement of cytotoxicity. This result shows that the arginine derivations improve liposomes' ability of taking up by macrophages and deliver drugs more efficiently and effectively.
Conclusions
Here, liposomes with surface modifications were studied for their ability to enhance drug delivery. Liposomes were modified with arginine derivatives. These modifications had no influence on particle size and drug loading efficiency. Differences were observed on the measured zeta potentials, which impacts internalization by macrophages. Cellular uptake of the liposomes was found to be dependent upon macrophage phenotype and surface modifications. There were also differences in trends between internalization of liposomal FC and the IC 50 of liposomal doxorubicin, which were attributed to changes in the ability of doxorubicin to escape the endosome. This work demonstrates the importance of investigating how liposomes interact with different macrophage types and the ability to preferentially deliver drugs to specific macrophage phenotypes. The results claims that liposomes modified with arginine derivation are promising efficient nanoparticle vehicles for delivery to macrophages.
